Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain

References

• Di Iorio D, Henley E, Doughty A. A survey of primary care physician practice patterns and adherence to acute low back problem guidelines. Arch Fam Med. 2000;9(10):1015–1021.
   PubMedGoogle Scholar
• Schers H, Braspenning J, Drijver R, et al. Low back pain in general practice: Reported management and reasons for not adhering to the guidelines in The Netherlands. Br J Gen Pract. 2000;50(457):640–644.
   PubMed Web of Science ®Google Scholar
• Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791–2803.
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Birnbaum HG, Schiller M, et al. Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care. Spine J. 2011;11(7):622–632.
   PubMed Web of Science ®Google Scholar
• Soprano SE, Hennessy S, Bilker WB, et al. Assessment of physician prescribing of muscle relaxants in the United States, 2005–2016. JAMA Netw Open. 2020;3(6):e207664.
   PubMedGoogle Scholar
• Schreijenberg M, Koes BW, Lin CC. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care - is there a need to change? Expert Rev Clin Pharmacol. 2019;12(2):145–157.
   PubMed Web of Science ®Google Scholar
• Ludwig WD, Seifert R, Mühlbauer B. Arzneiverordnungs report 2021. Berlin, Germany: Springer.
   Google Scholar
• Position of the co-ordination group for mutual recognition and decentralised procedures for human use on periodic safety update reports fortizanidine. [accessed March 6, 2022]. Available from: https://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/PSUSAS/s-z/tizanidin_beschluss_cmdh.pdf?__blob=publicationFile&v=2
   Google Scholar
• European Medicines Agency recommends restricting use of tolperisone medicines. [accessed March 6, 2022]. Available from: https://www.ema.europa.eu/en/documents/press-release/european-medicines-agency-recommends-restricting-use-tolperisone-medicines_en.pdf
   Google Scholar
• Recommendation to suspend tetrazepam-containing medicines endorsed by CMDh. [accessed March 6, 2022]. Available from: https://www.ema.europa.eu/en/documents/press-release/recommendation-suspend-tetrazepam-containing-medicines-endorsed-cmdh_en.pdf.
   Google Scholar
• PRAC recommends that the marketing authorisation of the painkiller flupirtine be withdrawn. [accessed March 6, 2022]. Available from: https://www.ema.europa.eu/en/documents/referral/prac-recommends-marketing-authorisation-painkiller-flupirtine-be-withdrawn_en.pdf
   Google Scholar
• Pridinol. Myopridin® 3 mg tablets (Strathmann) summary of product characteristics, last updated Aug 2019. [accessed March 6, 2022]. Available from: https://s3.eu-central-1.amazonaws.com/prod-cerebro-ifap/media_all/81560.pdf
   Google Scholar
• Pridinol – central and peripheral muscle spasms, lumbalgia, torticollis and general muscle pain. Article in German. [accessed on March 6, 2022]. Available from: https://www.kbv.de/media/sp/WirkstoffAktuell_4-21_Pridinol.pdf
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–189.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and Meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–W94.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Hoboken (NJ): Wiley; 2019.
   Google Scholar
• Leonardo R. PICO: model for clinical questions. Evid Based Med Pract. 2018;3:2.
   Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Furlan AD, Malmivaara A, Chou R, et al. 2015 Updated method guideline for systematic reviews in the cochrane back and neck group. Spine (Phila PA 1976). 2015;40(21):1660–1673.
   PubMed Web of Science ®Google Scholar
• Schünemann HJ, Mustafa R, Brozek J, et al. Grade guidelines: 16. grade evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89–98.
   PubMed Web of Science ®Google Scholar
• Moberg J, Oxman AD, Rosenbaum S, et al. The grade evidence to decision (ETD) framework for health system and public health decisions. Health Res Policy Syst. 2018;16(1):45.
   PubMed Web of Science ®Google Scholar
• Whitley E, Ball J. Statistics review 3: hypothesis testing and P values. Crit Care. 2002;6(3):222–225.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in Meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in Meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. New York (NY): Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Vancak V, Goldberg Y, Levine SZ. Systematic analysis of the number needed to treat. Stat Methods Med Res. 2020;29(9):2393–2410.
   PubMedGoogle Scholar
• Ichikawa N, Hirose K, Nakada A, et al. Clinical evaluation of loxeen by double blind method. Japan: Tobishi Pharmaceuticals Co., Ltd.; 1973.
   Google Scholar
• Isobe R, Umehara T, Ikenuma S, et al. Therapeutic effect of methanesulfonate pridinol upon spondylosis deformans, periarthritis humeroscapularis and cervico-omo-brachial – clinical data by double blind method. Japan: Tobishi Pharmaceuticals Co., Ltd.; 1973.
   Google Scholar
• Überall MA, Müller-Schwefe GHH, Horlemann J. Efficacy and tolerability of the antispasmodic pridinol in patients with muscle pain – results of a retrospective analysis of open-label real-world data provided by the german pain e-Registry. Cur Med Rev Opin. 2022. DOI:https://doi.org/10.1080/03007995.2022.2072089
   Google Scholar
• Refior HJ. Clarification of the concept of humeroscapular periarthritis. Orthopade. 1995;24(6):509–511.
   PubMedGoogle Scholar